Scarica l'app Stockscreener
1.65
0.61%
0.01
Dopo l'orario di chiusura:
1.66
0.01
+0.61%
Pmv Pharmaceuticals Inc Borsa (PMVP) Ultime notizie
Rezatapopt Monotherapy Remains Under Study Following Discontinuation of Combination Cohort in TP53+ Solid Tumors - OncLive
US Penny Stocks To Consider In October 2024 - Simply Wall St
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial - GlobeNewswire
SG Americas Securities LLC Invests $554,000 in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World
SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World
ELVN-001 Appears Safe and Effective in Relapsed/Refractory CML - OncLive
Envestnet Asset Management Inc. Sells 2,501 Shares of Juniper Networks, Inc. (NYSE:JNPR) - Defense World
Point72 Asia Singapore Pte. Ltd. Takes $101,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire
Pawan Singh sharing his grief with Mata Rani, asking questions from his mind, Pawan Singh sharing his grief with Mata Rani, asking questions from his mind - AnyTV News
Small Cap Stocks: Plexus, Parkmead, Proton Motor - The Armchair Trader
Stock market news: PC Jeweller shares hit 5% upper circuit- Check Details - MSN
Vanguard Personalized Indexing Management LLC Increases Position in PDD Holdings Inc. (NASDAQ:PDD) - Defense World
2 ASX shares I can’t ignore: PME and SOL - Rask Media
40% women with PCOD may get diabetes: Experts - The Times of India
Parvin Dabas, Pro Panja League Co-Founder, In ICU After Road Accident - Pratidin Time
Agency News | ⚡Pro Panja League Co-Founder and Actor Parvin Dabas Admitted to ICU Following Car Accident - LatestLY
Should PME shares be on your watchlist? - Rask Media
Power Mech Shares Gain on Securing Orders Worth Rs 865 Crore - EquityPandit
Power Mech rises on Rs 865-cr order win from Vedanta's subsidiary - Business Standard
Bowers & Wilkins Launches Px7 S2e “Ruby Red” and Px8 “Dark Forest” - HYPEBEAST
Bowers & Wilkins adds two new colors to PX7 S2e & PX8 headphones - Gstyle magazine
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India
Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat
PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India
Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio
NCCN Adds Denileukin Diftitox to CTCL Clinical Practice Guidelines in Oncology - OncLive
Dr Koff on the Role of Covalent BTK Inhibitors and Pirtobrutinib in MCL - OncLive
Closing Figures: PMV Pharmaceuticals Inc (PMVP)’s Negative Finish at 1.58, Down -1.25 - The Dwinnex
Assenagon Asset Management S.A. Has $401,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Envestnet Portfolio Solutions Inc. Buys 5,351 Shares of MBIA Inc. (NYSE:MBI) - Defense World
Gene and Cell Therapy: Shaping the Future of Medicine - OncLive
Assenagon Asset Management S.A. Boosts Stake in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - StockTitan
PMVP (PMV Pharmaceuticals) EPS (Basic) : $-0.97 (TTM As of Jun. 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) Purchase Of Investment : $-162.36 Mil (TTM As of Jun. 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) GF Value Rank : 0 (As of Aug. 19, 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) EV-to-Revenue : (As of Aug. 19, 2024) - GuruFocus.com
Vanguard Group Inc. Purchases 46,804 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
FDA Grants Fast Track Status to AC699 for ER+/HER2–, ESR1-Mutated Breast Cancer - OncLive
Small Clones, Outsized Consequences: The Many Faces of Clonal Hematopoiesis - OncLive
Panasonic (OTCMKTS:PCRFY) Stock Price Crosses Below Fifty Day Moving Average of $9.36 - Defense World
PMV Pharmaceuticals Initiates Strategic Lease Termination - TipRanks
PMV Pharmaceuticals Reports Second Quarter 2024 Financial - GlobeNewswire
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial - StockTitan
Public Employees Retirement System of Ohio Raises Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
FDA Requests Additional Demonstration of OS Benefit to Support Iomab-B BLA in R/R AML - OncLive
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Simply Wall St
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Bought by Jacobs Levy Equity Management Inc. - MarketBeat
IMNN-01 Plus Perioperative Chemo Improves OS in Newly Diagnosed, Advanced Ovarian Cancer - OncLive
Acadian Asset Management LLC Increases Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Acadian Asset Management LLC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Acquires Shares of 15,492 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
BNP Paribas Financial Markets Has $597,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
Mirae Asset Global Investments Co. Ltd. Buys New Stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Dr Shadman on the Evaluation of Zanbrutinib Plus Sonrotoclax in Treatment-Naive CLL - OncLive
Rezatapopt Takes Aim at Previously Untargetable p53 Allele to Treat Advanced Solid Tumors - OncLive
FDA Grants Priority Review to Tabelecleucel for Adult/Pediatric EBV+ Post-Transplant Lymphoproliferative Disease - OncLive
FDA Grants Fast Track Designation to DSP-5336 in KMT2A/NMP1+ AML - OncLive
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 0.6% - Defense World
PMV Pharmaceuticals (NASDAQ:PMVP) Shares Down 0.6% - MarketBeat
PMV Pharmaceuticals Inc (PMVP)’s stock chart: A technical perspective - US Post News
Dr Punekar on the Evaluation of NT-112 in KRAS G12D+ Advanced Solid Tumors - OncLive
A look into PMV Pharmaceuticals Inc (PMVP)’s deeper side - SETE News
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):